Friedl-Naderer Johanna
Dyne Therapeutics, Inc. · Chief Commercial Officer
Friedl-Naderer Johanna is listed in public filings as officer: Chief Commercial Officer. This Friedl-Naderer Johanna insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Dyne Therapeutics, Inc. (DYN). Investors use Friedl-Naderer Johanna's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $2.8M154.4k shares | SellMay 13, 2026 | $4.2K228 shares | $18.36 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $2.3M154.6k shares | SellMar 5, 2026 | $2.2K148 shares | $14.90 | -- | |
| $1.4M90k shares | Grant / ExerciseFeb 12, 2026 | $1.4M90k shares | $16.00 | -- | |
| --154.7k shares | Grant / ExerciseFeb 12, 2026 | Disclosure amount unavailable60k shares | -- | -- | |
| $2.0M94.7k shares | SellDec 5, 2025 | $3.0K144 shares | $20.72 | -- | |
| $1.3M94.9k shares | SellSep 5, 2025 | $1.9K144 shares | $13.41 | -- | |
| $1.3M95k shares | SellSep 4, 2025 | $11.9K894 shares | $13.27 | -- | |
| $478k51.3k shares | Grant / ExerciseJul 16, 2025 | $478.2K51.3k shares | $9.33 | -- | |
| $1.3M95.9k shares | SellJun 5, 2025 | $1.9K146 shares | $13.35 | -- | |
| $1.2M96.1k shares | SellMar 13, 2025 | $1.7K143 shares | $12.12 | -- | |
| $1.8M60.3k shares | Grant / ExerciseDec 4, 2024 | $1.8M60.3k shares | $29.44 | -- | |
| --96.2k shares | Grant / ExerciseDec 4, 2024 | Disclosure amount unavailable37.8k shares | -- | -- | |
| $5.9M185.3k shares | Grant / ExerciseSep 3, 2024 | $5.9M185.3k shares | $31.94 | -- | |
| --58.4k shares | Grant / ExerciseSep 3, 2024 | Disclosure amount unavailable58.4k shares | -- | -- |